ATF3, a transcription factor with a pro-death role in several stressful situations, has been reported to positively regulate apoptosis-inducing genes, such as DR5 and NOXA, and ATF3 knockdown increases the viability of multiple myeloma cells treated by bortezomib [64]. The gene discussed is ATF3; the disease is plasma cell myeloma.